|
1
|
Sarode GS, Sarode SC, Maniyar N, Anand R
and Patil S: Oral cancer databases: a comprehensive review. J Oral
Pathol Med. 47:547–556. 2018. View Article : Google Scholar
|
|
2
|
Ali J, Sabiha B, Jan HU, Haider SA, Khan
AA and Ali SS: Genetic etiology of oral cancer. Oral Oncol.
70:23–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Veeck J and Dahl E: Targeting the Wnt
pathway in cancer: The emerging role of Dickkopf-3. Biochim Biophys
Acta. 1825:18–28. 2012.
|
|
4
|
Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y
and Namba M: A REIC gene shows down-regulation in human
immortalized cells and human tumor-derived cell lines. Biochem
Biophys Res Commun. 268:20–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Katase N and Nohno T: DKK3 (dickkopf 3
homolog (Xenopus laevis)). Atlas Genet Cytogenet Oncol Haematol.
17:678–686. 2013.
|
|
6
|
Edamura K, Nasu Y, Takaishi M, Kobayashi
T, Abarzua F, Sakaguchi M, Kashiwakura Y, Ebara S, Saika T,
Watanabe M, et al: Adenovirus-mediated REIC/Dkk-3 gene transfer
inhibits tumor growth and metastasis in an orthotopic prostate
cancer model. Cancer Gene Ther. 14:765–772. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kawasaki K, Watanabe M, Sakaguchi M,
Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH,
Kumon H, et al: REIC/Dkk-3 overexpression downregulates
P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces
apoptosis in breast cancer. Cancer Gene Ther. 16:65–72. 2009.
View Article : Google Scholar
|
|
8
|
Fujii M, Katase N, Lefeuvre M, Gunduz M,
Buery RR, Tamamura R, Tsujigiwa H and Nagatsuka H: Dickkopf (Dkk)-3
and β-catenin expressions increased in the transition from normal
oral mucosal to oral squamous cell carcinoma. J Mol Histol.
42:499–504. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Katase N, Lefeuvre M, Gunduz M, Gunduz E,
Beder LB, Grenman R, Fujii M, Tamamura R, Tsujigiwa H and Nagatsuka
H: Absence of Dickkopf (Dkk)-3 protein expression is correlated
with longer disease-free survival and lower incidence of metastasis
in head and neck squamous cell carcinoma. Oncol Lett. 3:273–280.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katase N, Lefeuvre M, Tsujigiwa H, Fujii
M, Ito S, Tamamura R, Buery RR, Gunduz M and Nagatsuka H: Knockdown
of Dkk-3 decreases cancer cell migration and invasion independently
of the Wnt pathways in oral squamous cell carcinoma-derived cells.
Oncol Rep. 29:1349–1355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katase N, Nishimatsu SI, Yamauchi A,
Yamamura M, Terada K, Itadani M, Okada N, Hassan NMM, Nagatsuka H,
Ikeda T, et al: DKK3 overexpression increases the malignant
properties of head and neck squamous cell carcinoma cells. Oncol
Res. 26:45–58. 2018. View Article : Google Scholar
|
|
12
|
de Jonge HJ, Fehrmann RS, de Bont ES,
Hofstra RM, Gerbens F, Kamps WA, de Vries EG, van der Zee AG, te
Meerman GJ and ter Elst A: Evidence based selection of housekeeping
genes. PLoS One. 2:e8982007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Katase N, Terada K, Suzuki T, Nishimatsu S
and Nohno T: miR-487b, miR-3963 and miR-6412 delay myogenic
differentiation in mouse myoblast-derived C2C12 cells. BMC Cell
Biol. 16:132015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
|
|
15
|
Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar :
|
|
16
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBio-Portal. Sci Signal. 6:pp. pl12013,
View Article : Google Scholar
|
|
17
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et
al: A pathology atlas of the human cancer transcriptome. Science.
357:pp. eaan25072017, View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pickering CR, Zhang J, Yoo SY, Bengtsson
L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond
J, et al: Integrative genomic characterization of oral squamous
cell carcinoma identifies frequent somatic drivers. Cancer Discov.
3:770–781. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sharma V, Nandan A, Sharma AK, Singh H,
Bharadwaj M, Sinha DN and Mehrotra R: Signature of genetic
associations in oral cancer. Tumour Biol. 39:10104283177259232017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khayer N, Zamanian-Azodi M, Mansouri V,
Ghassemi-Broumand M, Rezaei-Tavirani M, Heidari MH and Rezaei
Tavirani M: Oral squamous cell cancer protein-protein interaction
network interpretation in comparison to esophageal adenocarcinoma.
Gastroenterol Hepatol Bed Bench. 10:118–124. 2017.PubMed/NCBI
|
|
22
|
Upadhyay P, Gardi N, Desai S, Chandrani P,
Joshi A, Dharavath B, Arora P, Bal M, Nair S and Dutt A: Genomic
characterization of tobacco/nut chewing HPV-negative early stage
tongue tumors identify MMP10 asa candidate to predict metastases.
Oral Oncol. 73:56–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nayak S, Goel MM, Makker A, Bhatia V,
Chandra S, Kumar S and Agarwal SP: Fibroblast growth factor (FGF-2)
and its receptors FGFR-2 and FGFR-3 may be putative biomarkers of
malignant transformation of potentially malignant oral lesions into
oral squamous cell carcinoma. PLoS One. 10:e01388012015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang KY, Tsai SY, Chen SH, Tsou HH, Yen
CJ, Liu KJ, Fang HL, Wu HC, Chuang BF, Chou SW, et al: Dissecting
the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the
EGFR variant III and its clinical relevance. J Biomed Sci.
20:432013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Katase N, Gunduz M, Beder L, Gunduz E,
Lefeuvre M, Hatipoglu OF, Borkosky SS, Tamamura R, Tominaga S,
Yamanaka N, et al: Deletion at Dickkopf (dkk)-3 locus (11p15.2) is
related with lower lymph node metastasis and better prognosis in
head and neck squamous cell carcinomas. Oncol Res. 17:273–282.
2008. View Article : Google Scholar
|
|
26
|
Katase N, Gunduz M, Beder LB, Gunduz E, Al
Sheikh Ali M, Tamamura R, Yaykasli KO, Yamanaka N, Shimizu K and
Nagatsuka H: Frequent allelic loss of Dkk-1 locus (10q11.2) is
related with low distant metastasis and better prognosis in head
and neck squamous cell carcinomas. Cancer Invest. 28:103–110. 2010.
View Article : Google Scholar
|
|
27
|
Chen L, Wang K, Shao Y, Huang J, Li X,
Shan J, Wu D and Zheng JJ: Structural insight into the mechanisms
of Wnt signaling antagonism by Dkk. J Biol Chem. 283:23364–23370.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fujii Y, Hoshino T and Kumon H: Molecular
simulation analysis of the structure complex of C2 domains of DKK
family members and β-propeller domains of LRP5/6: Explaining why
DKK3 does not bind to LRP5/6. Acta Med Okayama. 68:63–78. 2014.
|
|
29
|
Van Waes C and Musbahi O: Genomics and
advances towards precision medicine for head and neck squamous cell
carcinoma. Laryngoscope Investig Otolaryngol. 2:310–319. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang SQ, Wang X, Zheng K, Liu KS, Wang SX
and Xie CH: Simultaneous targeting PI3K and PERK pathways promotes
cell death and improves the clinical prognosis in esophageal
squamous carcinoma. Biochem Biophys Res Commun. 493:534–541. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Z, Valera JC, Zhao X, Chen Q and
Silvio Gutkind J: mTOR co-targeting strategies for head and neck
cancer therapy. Cancer Metastasis Rev. 36:491–502. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Simpson DR, Mell LK and Cohen EE:
Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of
the head and neck. Oral Oncol. 51:291–298. 2015. View Article : Google Scholar
|
|
33
|
Li SH, Chien CY, Huang WT, Luo SD, Su YY,
Tien WY, Lan YC and Chen CH: Prognostic significance and function
of mammalian target of rapamycin in tongue squamous cell carcinoma.
Sci Rep. 7:81782017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rogers SJ, Box C, Harrington KJ, Nutting
C, Rhys-Evans P and Eccles SA: The phosphoinositide 3-kinase
signalling pathway as a therapeutic target in squamous cell
carcinoma of the head and neck. Expert Opin Ther Targets.
9:769–790. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peterson TR, Laplante M, Thoreen CC,
Sancak Y, Kang SA, Kuehl WM, Gray NS and Sabatini DM: DEPTOR is an
mTOR inhibitor frequently overexpressed in multiple myeloma cells
and required for their survival. Cell. 137:873–886. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ji YM, Zhou XF, Zhang J, Zheng X, Li SB,
Wei ZQ, Liu T, Cheng DL, Liu P, Song K, et al: DEPTOR suppresses
the progression of esophageal squamous cell carcinoma and predicts
poor prognosis. Oncotarget. 7:14188–14198. 2016.PubMed/NCBI
|
|
37
|
Baldassarri M, Fallerini C, Cetta F,
Ghisalberti M, Bellan C, Furini S, Spiga O, Crispino S, Gotti G,
Ariani F, et al: Omic approach in non-smoker female with lung
squamous cell carcinoma pinpoints to germline susceptibility and
personalized medicine. Cancer Res Treat. 50:356–365. 2018.
View Article : Google Scholar :
|
|
38
|
Gao D, Inuzuka H, Tan MK, Fukushima H,
Locasale JW, Liu P, Wan L, Zhai B, Chin YR, Shaik S, et al: mTOR
drives its own activation via SCF(βTrCP)-dependent degradation of
the mTOR inhibitor DEPTOR. Mol Cell. 44:290–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park
J, Chae M, Zhang W and Lee JH: Dkk3, downregulated in cervical
cancer, functions as a negative regulator of beta-catenin. Int J
Cancer. 124:287–297. 2009. View Article : Google Scholar
|
|
40
|
Leonard JL, Leonard DM, Wolfe SA, Liu J,
Rivera J, Yang M, Leonard RT, Johnson JPS, Kumar P, Liebmann KL, et
al: The Dkk3 gene encodes a vital intracellular regulator of cell
proliferation. PLoS One. 12:e01817242017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Warner KA, Miyazawa M, Cordeiro MM, Love
WJ, Pinsky MS, Neiva KG, Spalding AC and Nör JE: Endothelial cells
enhance tumor cell invasion through a crosstalk mediated by CXC
chemokine signaling. Neoplasia. 10:131–139. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hosono M, Koma YI, Takase N, Urakawa N,
Higashino N, Suemune K, Kodaira H, Nishio M, Shigeoka M, Kakeji Y,
et al: CXCL8 derived from tumor-associated macrophages and
esophageal squamous cell carcinomas contributes to tumor
progression by promoting migration and invasion of cancer cells.
Oncotarget. 8:106071–106088. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang J, He X, Ma Y, Liu Y, Shi H, Guo W
and Liu L: Overexpression of ROCK1 and ROCK2 inhibits human
laryngeal squamous cell carcinoma. Int J Clin Exp Pathol.
8:244–251. 2015.PubMed/NCBI
|
|
44
|
Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ,
Kuo MY and Chiang CP: Expression of hypoxia-inducible factor-1
alpha is significantly associated with the progression and
prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol
Med. 37:18–25. 2008. View Article : Google Scholar
|
